Skip to main content

Infleqtion, Inc.

For the period ended Mar 31, 2026. Filed May 15, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 15, 2026

INFQ$9.35-3.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (unaudited)

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

(Unaudited; in thousands, except share amounts)

Convertible Redeemable Preferred Stock · Stockholders’ Equity (Deficit)
Series Seed · Series Seed II · Series A · Series B · Series B-1 · Series C · Series C-1 · Common Stock · Additional Paid-in Capital · Accumulated Deficit · Accumulated Other Comprehensive (Loss) Income · Total Stockholders’ Equity (Deficit)
Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount
Balances as of December 31, 2024 (as previously reported)24,871,033$6,52627,499,984$10,411101,515,976$36,658113,956,319$112,14532,419,574$32,99020,508,938$22,50322,869,771$26,35145,512,715$5$15,751$(199,291)$360$(183,175)
Conversion of stock(16,230,759)—(17,946,404)—(66,249,009)—(74,367,538)—(21,156,913)—(13,384,069)—(14,924,741)—(29,701,456)(3)3———
Balance at December 31, 2024, effect of reverse recapitalization8,640,274$6,5269,553,580$10,41135,266,967$36,65839,588,781$112,14511,262,661$32,9907,124,869$22,5037,945,030$26,35115,811,259$2$15,754$(199,291)$360$(183,175)
Net loss—————————————————(5,985)—(5,985)
Stock-based compensation expense—————————————1,118——1,118
Stock options exercised——————————————829,985—371——371
Other comprehensive income——————————————————416416
Balances as of March 31, 20258,640,274$6,5269,553,580$10,41135,266,967$36,65839,588,781$112,14511,262,661$32,9907,124,869$22,5037,945,030$26,35116,641,244$2$17,243$(205,276)$776$(187,255)
Balances as of December 31, 2025 (as previously reported)24,871,033$6,52627,499,984$10,411101,515,976$36,658113,956,319$112,14532,419,574$32,99060,399,952$71,73322,869,771$26,35150,227,011$5$21,928$(231,086)$906$(208,247)
Conversion of stock(16,230,759)—(17,946,404)—(66,249,009)—(74,367,538)—(21,156,913)—(39,416,820)—(14,924,741)—(32,777,991)(3)3———
Balance at December 31, 2025, effect of reverse recapitalization8,640,274$6,5269,553,580$10,41135,266,967$36,65839,588,781$112,14511,262,661$32,99020,983,132$71,7337,945,030$26,35117,449,020$2$21,931$(231,086)$906$(208,247)
Net loss—————————————————(30,263)—(30,263)
Stock-based compensation expense————————————————8,293——8,293
Stock options exercised——————————————1,115,543—771——771
Merger recapitalization(8,640,274)($6,526)(9,553,580)($10,411)(35,266,967)($36,658)(39,588,781)($112,145)(11,262,661)($32,990)(20,983,132)($71,733)(7,945,030)($26,351)133,240,42513296,801——296,814
CCX shares recapitalized, net of equity issuance costs——————————————64,666,9397518,861——518,868
Other comprehensive loss——————————————————(981)(981)
Balances as of March 31, 2026——————————————216,471,927$22846,657(261,349)$(75)$585,255
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.